Convergence of technology and the aging population are opening up many new markets to astute market leaders. We assist medical device, diagnostics, and pharmaceutical companies to develop and drive growth initiatives, validate adjacent markets, identify out-of-industry technologies, extend API exclusivity with alternative drug delivery devices, and identify corporate investment or acquisition opportunities.